Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Sunday, September 27

5:00 PM - 5:10 PM ET

132 - Long-Term Outcomes from a Phase 2 Trial of Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma
Speaker: Li, Xingzhe, MD, MPH - UT Southwestern Medical Center, Dallas, TX
5:00 PM - 5:10 PM ET

138 - State Paid Family Leave Policies, Informal Family Caregivers and Cancer Mortality among Older Adults
Speaker: Barnes, Justin, MD, MS - Mayo Clinic Alix School of Medicine, Rochester, MN
5:00 PM - 5:10 PM ET

143 - Computationally Efficient Low Field MRI Enhancement via Foundation Model Feature Engineering
Speaker: Liu, Lianli, PhD - Stanford University, Stanford, CA
5:00 PM - 5:05 PM ET

Introduction
Speaker: Brady, Jessica, MD, MB, ChB - Guy's and St Thomas' NHS Trust, London, London
5:00 PM - 5:20 PM ET

Introductions
Speaker: Osmundson, Evan, MD, PhD - Vanderbilt-Ingram Cancer Center, Nashville, TN
5:05 PM - 5:10 PM ET

1084 - Solitary Plasmacytoma Treated by Lenalidomide and Dexamethasone in Combination with Radiation Therapy: Long Term Clinical Outcomes
Speaker: Kirova, Youlia, MD - Institut Curie, Paris, Paris
5:10 PM - 5:15 PM ET

1085 - A Phase II Single-arm Study of Total Body Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) Total Body Irradiation (TBI)
Speaker: Shaikh, Fauzia, MD - NYU Langone Health- Radiation Oncology, New York, NY
5:10 PM - 5:20 PM ET

133 - Efficacy and Safety of Targeted-Immunotherapy with or without Stereotactic Ablative Radiotherapy for Recurrent/Metastatic Renal Cell Carcinoma: The Result of a Multicenter Ambidirectional cohort study
Speaker: Hu, Ke, MD - Peking University First Hospital, Beijing, Beijing
5:10 PM - 5:20 PM ET

139 - Characterization of Laboratory Eligibility Criteria In Phase III Oncology Trials: A Meta-Epidemiological Analysis
Speaker: Pocha, Olivia, MS, BS - Tulane University School of Medicine, New Orleans, LA
5:10 PM - 5:20 PM ET

144 - Single-CT Simulation for Surface-Guided DIBH Radiotherapy Using Deep Learning-Synthesized 3D Body Contours from Scout Images
Speaker: Lee, Inbum, PhD - Seoul National University Hospital, Seoul, SEO
5:15 PM - 5:20 PM ET

1086 - PD-1/PD-L1 Blockade Added to First-Line Asparaginase-Based Chemotherapy with or without Radiotherapy in Extranodal Nasal-Type NK/T-Cell Lymphoma: A Multicenter Retrospective Study from the CLCG
Speaker: Liu, Yue, MD - National Cancer Center CAMS & PUMC, Beijing, Beijing
5:20 PM - 5:25 PM ET

1018 - Phase 1 Trial of CT-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for Treatment of Ultra-Central Early-Stage Non-Small Cell Lung Cancer (NSCLC)
Speaker: D'Souza, Alden, MD, MPHS - Washington University in St. Louis School of Medicine, St Louis, MO